Zenith Epigenetics Announces Start of Several NCI-Sponsored Oncology Trials
06 Jul 2022 //
GLOBENEWSWIRE
Zenith Epigenetics TNBC Clinical Data Highlighted in an Oral Discussion at ASCO
21 Jun 2022 //
GLOBENEWSWIRE
Zenith commences Phase IIb breast cancer combination therapy trial
11 May 2022 //
CLINICALTRIALSARENA
Zenith Epigenetics Announces Initiation of PIIb TNBC Trial
10 May 2022 //
GLOBENEWSWIRE
Zenith Epigenetics Begins Dosing of Combination of ZEN-3694 + BMS` OPDIVO
22 Feb 2022 //
BIOSPACE
Zenith Epigenetics Announces a Publication in the Journal of Cancer Gene Therapy
17 Aug 2021 //
GLOBENEWSWIRE
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694
24 Jun 2021 //
GLOBENEWSWIRE
Zenith Epigenetics Announces Clinical Collaboration with Astellas
22 Apr 2021 //
GLOBENEWSWIRE
Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694
05 Oct 2020 //
GLOBENEWSWIRE
Zenith Epigenetics Advances ZEN-3694 in Multiple Cancer Programs
29 Jul 2020 //
GLOBENEWSWIRE
Zenith Epigenetics Announces Clinical Advancement of ZEN-3694
19 Dec 2019 //
GLOBE NEWSWIRE